Clinical Trials Sponsored by National Institute of Regenerative Medicine

Total 28351 results

Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Adipose Derived Stem Cell Therapy for Autism

Autism

United States
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Safety and Efficacy of Adipose Derived Stem Cells for Non-Ischemic Congestive Heart Failure

Non-Ischemic Congestive Heart Failure

Mexico
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stem Cells in Patients With Frailty Syndrome

Frailty Syndrome

Mexico
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Diffuse Lesions in the Brain

Brain Lesion (General)

Mexico
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Renal Failure

Renal Failure

Mexico
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Safety and Efficacy of Adipose Derived Stem Cells for Congestive Heart Failure

Ischemic Congestive Heart Failure

Mexico
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Study to Assess the Safety and Cardiovascular Effects of Autologous Adipose-Derived Stromal Cells Implantation In Patients During the Acute Recovery Phase of ST-Elevation Myocardial Infarction (Acute MI)

Acute Myocardial Infarction

United States
Ageless Regenerative Institute
Instituto de Medicina Regenerativa

Withdrawn

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke

Stroke

Mexico
Institute of Regenerative and Cellular Medicine

Unknown

Safety and Clinical Effectiveness of A3 SVF in Osteoarthritis

Osteoarthritis

United States
Instituto de Medicina Regenerativa

Recruiting

Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms

Neoplasms

Mexico
Instituto de Medicina Regenerativa

Active, not recruiting

Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19

Covid-19 | ARDS, Human

Mexico
COR clinic of Regenerative Medicine

Completed

Skin Rejuvenation Using Stem Cell Secretome

Skin Rejuvenation

Lebanon
Instituto de Medicina Regenerativa

Completed

Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms

Neoplasms

Mexico
American Academy of Regenerative Medicine

Unknown

Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline

Age-related Cognitive Decline
ViaCyte
California Institute for Regenerative Medicine (CIRM)

Terminated

A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus

Type 1 Diabetes Mellitus

Canada, United States
Regenerative Medicine Network
University of Leipzig

Completed

Examination of B Cell Responses in Human Blood

HIV Infections

Germany
jCyte, Inc
California Institute for Regenerative Medicine (CIRM)

Completed

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

Retinitis Pigmentosa

United States
Astellas Institute for Regenerative Medicine

Completed

Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Stargardt's Macular Dystrophy

United Kingdom
Astellas Institute for Regenerative Medicine

Completed

A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Stargardt's Macular Dystrophy

United Kingdom
Astellas Institute for Regenerative Medicine

Completed

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Age-Related Macular Degeneration

United States
Gilead Sciences
California Institute for Regenerative Medicine (CIRM)

Completed

CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United Kingdom
National Institute of Blood and Marrow Transplant...
Armed Forces Institute of Regenerative Medicine

Completed

Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study

Spinal Cord Injury

Pakistan
Genascence Corporation
California Institute for Regenerative Medicine (CIRM)

Recruiting

Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis (DONATELLO)

Knee Osteoarthritis | Osteoarthritis, Knee | Osteo Arthritis Knee

United States
Angiocrine Bioscience
California Institute for Regenerative Medicine (CIRM)

Terminated

A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (E-CELERATE)

Hodgkin Lymphoma | Non Hodgkin Lymphoma

United States
jCyte, Inc
California Institute for Regenerative Medicine (CIRM)

Completed

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

Retinitis Pigmentosa

United States
Angiocrine Bioscience
California Institute for Regenerative Medicine (CIRM)

Completed

Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

Hodgkin Lymphoma | Non-hodgkin Lymphoma

United States
Astellas Institute for Regenerative Medicine

Completed

Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (Dry AMD)

Dry Age Related Macular Degeneration

United States
Astellas Institute for Regenerative Medicine

Completed

Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy

Stargardt's Macular Dystrophy

United States
Gilead Sciences
California Institute for Regenerative Medicine (CIRM)

Completed

Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer

Colorectal Cancer | Solid Tumor

United States
Astellas Institute for Regenerative Medicine

Completed

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

Stargardt's Macular Dystrophy

United States
Astellas Institute for Regenerative Medicine

Withdrawn

Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD (PORTRAY)

Age-Related Macular Degeneration

United States
University of Utah
Cell Therapy & Regenerative Medicine

Recruiting

Sterile Amniotic Fluid Filtrate Epidural Injection.

Lumbar Spinal Stenosis

United States
Neurona Therapeutics
California Institute for Regenerative Medicine (CIRM)

Recruiting

FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

United States
Astellas Institute for Regenerative Medicine

Recruiting

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Astellas Institute for Regenerative Medicine

Enrolling by invitation

A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy

Macular Degenerative Disease

United Kingdom, United States
ExCellThera inc.
California Institute for Regenerative Medicine (CIRM)

Withdrawn

US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease

Sickle Cell Disease | Umbilical Cord Blood | Hematopoietic Cell Proliferation

United States
Angiocrine Bioscience
California Institute for Regenerative Medicine (CIRM)

Completed

Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia in Remission | Other Acute Leukemias

United States
jCyte, Inc
California Institute for Regenerative Medicine (CIRM)

Completed

Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa

Retinitis Pigmentosa (RP)

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI); California Institute for Regenerative Medicine...

Active, not recruiting

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

HIV Infection | Plasmablastic Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Stage III Follicular... and other conditions

United States
University of California, Los Angeles
National Eye Institute (NEI); California Institute for Regenerative Medicine...

Recruiting

Stem Cell Therapy for Limbal Stem Cell Deficiency

Limbal Stem-cell Deficiency

United States
Immune-Onc Therapeutics
California Institute for Regenerative Medicine (CIRM)

Recruiting

IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

CMML | AML With Monocytic Differentiation

United States
Poseida Therapeutics, Inc.
California Institute for Regenerative Medicine (CIRM)

Terminated

P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)

Multiple Myeloma

United States
Rocket Pharmaceuticals Inc.
California Institute for Regenerative Medicine (CIRM)

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

Leukocyte Adhesion Defect - Type I

Spain, United States, United Kingdom
Rocket Pharmaceuticals Inc.
California Institute for Regenerative Medicine (CIRM)

Terminated

A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis

Infantile Malignant Osteopetrosis

United States
City of Hope Medical Center
National Cancer Institute (NCI); California Institute for Regenerative Medicine...

Recruiting

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Breast Cancer | HER2-positive Breast Cancer | Malignant Neoplasm | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the Leptomeninges

United States
City of Hope Medical Center
National Cancer Institute (NCI); California Institute for Regenerative Medicine...

Active, not recruiting

Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma

Asymptomatic COVID-19 Infection Laboratory-Confirmed | Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
City of Hope Medical Center
California Institute for Regenerative Medicine (CIRM)

Active, not recruiting

A Blood Stem Cell Transplant for Sickle Cell Disease

Sickle Cell Disease | Anemia, Sickle Cell | Hemoglobinopathies | Thalassemia | Sickle Cell Disorder

United States
Brainstorm-Cell Therapeutics
California Institute for Regenerative Medicine (CIRM)

Completed

Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients

Amyotrophic Lateral Sclerosis (ALS)

United States
Medeor Therapeutics, Inc.
California Institute for Regenerative Medicine (CIRM)

Active, not recruiting

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

Kidney Transplant Rejection

United States, Canada
Institute of Hematology & Blood Diseases Hospital
Bejing Institute for Stem Cell and Regenerative Medicine; Institute for Stem...

Recruiting

Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia

Refractory Leukemia | Relapsed Leukemia | Acute Myeloid Leukemia, Childhood

China

Clinical Trials Sponsored by National Institute of Regenerative Medicine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations